JP7801240B2 - 病原体診断検査 - Google Patents

病原体診断検査

Info

Publication number
JP7801240B2
JP7801240B2 JP2022560915A JP2022560915A JP7801240B2 JP 7801240 B2 JP7801240 B2 JP 7801240B2 JP 2022560915 A JP2022560915 A JP 2022560915A JP 2022560915 A JP2022560915 A JP 2022560915A JP 7801240 B2 JP7801240 B2 JP 7801240B2
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
certain embodiments
synthetic
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022560915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520590A5 (https=
JP2023520590A (ja
Inventor
コスリ，スリラム
ジョーンズ，エリック，マチュー
クーパー，アーロン
ガスペリーニ，モリー，ジャネット
Original Assignee
オクタント，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オクタント，インク． filed Critical オクタント，インク．
Publication of JP2023520590A publication Critical patent/JP2023520590A/ja
Publication of JP2023520590A5 publication Critical patent/JP2023520590A5/ja
Application granted granted Critical
Publication of JP7801240B2 publication Critical patent/JP7801240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2022560915A 2020-04-06 2021-04-05 病原体診断検査 Active JP7801240B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063005996P 2020-04-06 2020-04-06
US63/005,996 2020-04-06
US202063062406P 2020-08-06 2020-08-06
US63/062,406 2020-08-06
US202163136449P 2021-01-12 2021-01-12
US63/136,449 2021-01-12
US202163154571P 2021-02-26 2021-02-26
US63/154,571 2021-02-26
PCT/US2021/025806 WO2021207091A1 (en) 2020-04-06 2021-04-05 Pathogen diagnostic test

Publications (3)

Publication Number Publication Date
JP2023520590A JP2023520590A (ja) 2023-05-17
JP2023520590A5 JP2023520590A5 (https=) 2024-04-10
JP7801240B2 true JP7801240B2 (ja) 2026-01-16

Family

ID=75675001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560915A Active JP7801240B2 (ja) 2020-04-06 2021-04-05 病原体診断検査

Country Status (11)

Country Link
US (2) US12129523B2 (https=)
EP (2) EP4286538A3 (https=)
JP (1) JP7801240B2 (https=)
KR (1) KR20220164745A (https=)
CN (1) CN115917002A (https=)
AU (1) AU2021251703A1 (https=)
BR (1) BR112022020143A2 (https=)
CA (1) CA3179579A1 (https=)
IL (1) IL297033A (https=)
MX (1) MX2022012516A (https=)
WO (1) WO2021207091A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230019965A (ko) * 2020-06-22 2023-02-09 주식회사 씨젠 검체 내 타겟 핵산 서열 검출을 위한 준비물을 제공하는 방법
CA3240812A1 (en) * 2021-12-22 2023-06-29 Carter BARGER Quality control for reporter screening assays
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265796A1 (en) 2003-04-17 2004-12-30 Thomas Briese Methods and kits for detecting SARS-associated coronavirus
JP2009519010A (ja) 2005-11-28 2009-05-14 アイビス バイオサイエンシズ インコーポレイティッド 外来混入ウイルスの同定に使用するための組成物
US20090181360A1 (en) 2007-12-21 2009-07-16 Jules Chen Multiplex detection assay for influenza and rsv viruses
US20130266931A1 (en) 2010-07-16 2013-10-10 Tocagen Inc. Retrovirus detection
JP2014522646A (ja) 2011-07-06 2014-09-08 クエスト ダイアグノスティクス インベストメンツ インコーポレイテッド ウイルスおよび細菌病原体の直接増幅および検出
US20160281131A1 (en) 2014-10-08 2016-09-29 Theranos, Inc. Methods and Devices for Real-Time Diagnostic Testing (RDT) for Ebola and other Infectious Diseases
JP2017209036A (ja) 2016-05-24 2017-11-30 東洋紡株式会社 改良されたウイルス検出方法
WO2018198682A1 (ja) 2017-04-26 2018-11-01 東洋紡株式会社 ウイルスの検査方法およびウイルスの検査用キット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101384730A (zh) * 2005-12-23 2009-03-11 阿尔维德医药技术公司 用于传染病和癌症检测的分子信标成像的方法和应用
JP6873921B2 (ja) * 2015-05-18 2021-05-19 カリウス・インコーポレイテッド 核酸の集団を濃縮するための組成物および方法
JP7796660B2 (ja) * 2020-03-09 2026-01-09 エフ． ホフマン－ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）、インフルエンザａ及びインフルエンザｂを検出するための組成物及び方法
CN111494616A (zh) * 2020-04-27 2020-08-07 重庆医科大学附属永川医院 一种新冠病毒免疫增强型基因疫苗及其制备方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265796A1 (en) 2003-04-17 2004-12-30 Thomas Briese Methods and kits for detecting SARS-associated coronavirus
JP2009519010A (ja) 2005-11-28 2009-05-14 アイビス バイオサイエンシズ インコーポレイティッド 外来混入ウイルスの同定に使用するための組成物
US20090181360A1 (en) 2007-12-21 2009-07-16 Jules Chen Multiplex detection assay for influenza and rsv viruses
US20130266931A1 (en) 2010-07-16 2013-10-10 Tocagen Inc. Retrovirus detection
JP2014522646A (ja) 2011-07-06 2014-09-08 クエスト ダイアグノスティクス インベストメンツ インコーポレイテッド ウイルスおよび細菌病原体の直接増幅および検出
US20160281131A1 (en) 2014-10-08 2016-09-29 Theranos, Inc. Methods and Devices for Real-Time Diagnostic Testing (RDT) for Ebola and other Infectious Diseases
JP2017209036A (ja) 2016-05-24 2017-11-30 東洋紡株式会社 改良されたウイルス検出方法
WO2018198682A1 (ja) 2017-04-26 2018-11-01 東洋紡株式会社 ウイルスの検査方法およびウイルスの検査用キット

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Infectious Disease Quality Controls，Asuragen，2025年05月21日，https://asuragen.com/moleculardx-controls-portfolio/mdx-catalog-products/, 2017/12/19公開
Joungha WON，Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)，Experimental Neurobiology，2020年03月11日，Vol. 29，No. 2，p.107-119，DOI: 10.5607/en20009

Also Published As

Publication number Publication date
WO2021207091A1 (en) 2021-10-14
MX2022012516A (es) 2023-01-19
JP2023520590A (ja) 2023-05-17
CN115917002A (zh) 2023-04-04
BR112022020143A2 (pt) 2023-02-28
EP4286538A3 (en) 2024-03-20
US12129523B2 (en) 2024-10-29
AU2021251703A1 (en) 2022-11-10
CA3179579A1 (en) 2021-10-14
EP4286538A2 (en) 2023-12-06
US20220356535A1 (en) 2022-11-10
IL297033A (en) 2022-12-01
EP4133103A1 (en) 2023-02-15
US20250084492A1 (en) 2025-03-13
KR20220164745A (ko) 2022-12-13

Similar Documents

Publication Publication Date Title
Yang et al. Direct metatranscriptome RNA-seq and multiplex RT-PCR amplicon sequencing on nanopore MinION–promising strategies for multiplex identification of viable pathogens in food
US9598737B2 (en) Next generation genomic sequencing methods
US20250084492A1 (en) Pathogen diagnostic test
Pestana et al. Early, rapid and sensitive veterinary molecular diagnostics-real time PCR applications
JP2013531983A (ja) 多重生物検出のための核酸ならびにその使用および製造方法
AU2017203556B2 (en) Ion torrent genomic sequencing
WO2017049285A1 (en) Virome capture sequencing platform, methods of designing and constructing and methods of using
US20240279751A1 (en) A rapid multiplex rpa based nanopore sequencing method for real-time detection and sequencing of multiple viral pathogens
JP2016520326A (ja) マルチプレックス配列決定のための分子バーコード化
JP2023519919A (ja) 病原体を検出するためのアッセイ
Roy et al. Diverse molecular techniques for early diagnosis of COVID-19 and other coronaviruses
WO2017142989A1 (en) Nucleic acid preparation and analysis
CN117604132A (zh) 用于检测呼吸道病原体核酸的引物探针组合及试剂盒
Rahman et al. Development of a culture-independent whole-genome sequencing of Nipah virus using the MinION Oxford Nanopore platform
Mukherjee et al. Leveraging CRISPR-Cas-Enhanced isothermal amplification tools for quick identification of pathogens causing livestock diseases
EP4229221B1 (en) Method for parallel nucleic acid analysis
HK40097173A (en) Pathogen diagnostic test
WO2024030342A1 (en) Methods and compositions for nucleic acid analysis
EP3985129A1 (en) Method for parallel nucleic acid analysis
Xi et al. Differentiation of the seven major lyssavirus species by oligonucleotide microarray
CN113549709A (zh) 利用巢式RPA技术检测SARS-CoV-2的引物对、探针、试剂盒及其应用
US20250129438A1 (en) Assay for detection of sars-cov-2
US20250122586A1 (en) Compositions and methods for the detection of h3n2 influenza variants
Kalland et al. Molecular Microbial Diagnostics
Farraj Assay as a Diagnostic Tool for Infectious Disease

Legal Events

Date Code Title Description
RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20230117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240329

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260105

R150 Certificate of patent or registration of utility model

Ref document number: 7801240

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150